SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest eventreported): January 13, 2004
| TheraSense, Inc. | ||
| (Exact Name of Registrant as Specified In its Charter) | ||
| Delaware (State or Other Jurisdiction of Incorporation) |
| 000-33139 | 94-3267373 | |
| (Commission File Number) | (I.R.S. Employer Identification No.) | |
| 1360
South Loop Road, Alameda, California |
94502 | |
| (Address of Principal Executive Offices) | (Zip Code) |
(510)
749-5400
(Registrant’s Telephone Number, Iincluding Area Code)
Not
Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Item 5. Other Events.
On January 13, 2004, TheraSense, Inc. and Abbott Laboratories issued the joint press release attached as an exhibit in Item 7 to this Current Report on Form 8-K, and the contents contained therein are incorporated by reference herein.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
| 99.1 | Press Release dated January 13, 2004 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| THERASENSE, INC. | |||
| Date: January 13, 2004 | By: | /s/ W. Mark Lortz | |
| Name: Title: |
W. Mark
Lortz President, Chief Executive Officer and Chairman |
||